Nowadays ‘liquid biopsies,’ the notion of detecting cancer using only a blood test to detect minute amounts of circulating tumor are fairly well-known. But what if not even a blood test was needed to detect cancer, merely a few lungfuls of air?
Biotech landlord and developer Alexandria Real Estate Equities has purchased an office complex in Palo Alto’s Stanford Research Park from Stanford University for $100.3 million.
Maryland universities are creating new academic programs they say could help the state adapt to a changing innovation economy and help meet needs for tomorrow’s educators. The Education Policy and Student Life committee of the University System of Maryland’s Board of Regents moved forward this week with eight new programs proposed from system universities.
Maryland’s overall venture capital haul for 2018 totaled crossed the billion-dollar mark for the first time since 2001, according to the PwC/CB Insights MoneyTree report.
Without a doubt, Frederick’s life sciences and biotechnology industry is closing out the year with strong growth, and starting 2019 with a solid foundation built on numerous innovative organizations and several areas of expertise.
The Montgomery County Economic Development Corporation (MCEDC) and its board are pleased to welcome Bill Tompkins as Chief Operating Officer. Bill brings to Montgomery County a strong corporate and trade association background, having served in multiple senior level roles for Fortune 500 and other organizations.
The hire is well known in the business community for her previous roles at local organizations.
Pappas Capital has raised $85.8 million toward a venture-capital fund, according to a filing with the SEC.
A. M. Pappas Life Science Ventures V attracted capital from 29 LPs.
Study participants will use emocha’s platform to video record themselves each day for 24 weeks as they take buprenorphine.
While the high cost of living in San Francisco has famously grabbed headlines, the costs of simply meeting there, even for a few days, are becoming untenable for some.
As 9,000 official badge holders—alongside what could feel like three times as many unofficial attendees—swarmed downtown San Francisco for the annual J.P. Morgan Healthcare Conference, much of the opening small talk in the hastily bedless hotel suites-turned-meeting rooms began with, “Can you believe some of these prices?”
